EMEA-001256-PIP02-12-M02
Key facts
| Active substance |
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0362/2018
|
| PIP number |
EMEA-001256-PIP02-12-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Lens therapeutic procedures
|
| Route(s) of administration |
|
| Contact for public enquiries |
Omeros Corporation
E-mail: swhitaker@omeros.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|